Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2004-7-30
pubmed:abstractText
Many cardiovascular disease states end in progressive heart failure. Changes in intracellular calcium handling, including a reduced activity of the sarcoplasmic reticulum calcium pump (SERCA), contribute to this contractile dysfunction. As the regulatory protein phospholamban can inhibit the calcium pump, we evaluated it as a potential target to improve cardiac function. In this study, we describe a recombinant antibody-based protein (PLN-Ab) that binds to the cytoplasmic domain of phospholamban. Fluorescence resonance energy transfer (FRET) studies suggest that PLN-Ab mimics the effects of phospholamban phosphorylation. PLN-Ab accelerated the decay of the calcium transient when expressed in neonatal rat and adult mouse ventricular cardiac myocytes. In addition, direct injection of adenovirus encoding PLN-Ab into the diabetic mouse heart enhanced contractility when measured in vivo by echocardiography and in ex vivo Langendorff perfused hearts. The PLN-Ab provides a novel therapeutic approach to improving contractility through in vivo expression of an antibody inside cardiac myocytes.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1530-6860
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
18
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1312-4
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:15180962-Amino Acid Sequence, pubmed-meshheading:15180962-Animals, pubmed-meshheading:15180962-Antibody Specificity, pubmed-meshheading:15180962-Base Sequence, pubmed-meshheading:15180962-Calcium Signaling, pubmed-meshheading:15180962-Calcium-Binding Proteins, pubmed-meshheading:15180962-Calcium-Transporting ATPases, pubmed-meshheading:15180962-Cardiotonic Agents, pubmed-meshheading:15180962-Cell Line, pubmed-meshheading:15180962-Chickens, pubmed-meshheading:15180962-Diabetes Mellitus, Experimental, pubmed-meshheading:15180962-Fluorescence Resonance Energy Transfer, pubmed-meshheading:15180962-Gene Therapy, pubmed-meshheading:15180962-Heart Failure, pubmed-meshheading:15180962-Heart Ventricles, pubmed-meshheading:15180962-Humans, pubmed-meshheading:15180962-Immunoglobulins, pubmed-meshheading:15180962-Kidney, pubmed-meshheading:15180962-Mice, pubmed-meshheading:15180962-Molecular Mimicry, pubmed-meshheading:15180962-Molecular Sequence Data, pubmed-meshheading:15180962-Myocardial Contraction, pubmed-meshheading:15180962-Myocytes, Cardiac, pubmed-meshheading:15180962-Peptide Fragments, pubmed-meshheading:15180962-Phosphorylation, pubmed-meshheading:15180962-Protein Binding, pubmed-meshheading:15180962-Protein Structure, Tertiary, pubmed-meshheading:15180962-Rats, pubmed-meshheading:15180962-Recombinant Fusion Proteins
pubmed:year
2004
pubmed:articleTitle
A recombinant antibody increases cardiac contractility by mimicking phospholamban phosphorylation.
pubmed:affiliation
Department of Medicine, University of California, San Diego, La Jolla, CA 92093-0618, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't